Pioglitazone
Cat.No:IP3670 Solarbio
CAS:111025-46-8
Molecular Formula:C19H20N2O3S
Molecular Weight:356.44
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Cell Cycle > PioglitazoneCAS:111025-46-8
Molecular Formula:C19H20N2O3S
Molecular Weight:356.44
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 111025-46-8 |
| Name | Pioglitazone |
| Molecular Formula | C19H20N2O3S |
| Molecular Weight | 356.44 |
| Solubility | Soluble in DMSO ≥1mg/mL;Soluble in Water < 0.1mg/mL |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 601-029-7 |
| MDL | MFCD00865504 |
| SMILES | O=C(N1)SC(CC2=CC=C(OCCC3=NC=C(CC)C=C3)C=C2)C1=O |
| InChIKey | HYAFETHFCAUJAY-UHFFFAOYSA-N |
| InChI | InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23) |
| PubChem CID | 4829 |
| Target Point | PPAR |
| Passage | Cell Cycle;DNA Damage/DNA Repair;Metabolic Enzyme&Protease |
| Background | Pioglitazone is a potent and selective PPARγ agonist that binds with high affinity to the PPARγ ligand-binding domain. |
| Biological Activity | Pioglitazone 是一种有效的选择性 PPARγ 激动剂,高亲和力结合到 PPARγ 配体结合域。作用于人和鼠 PPARγ,EC50 分别为 0.93 和 0.99 μM。[1-4] |
| Data Literature Source | [1]. Kuwabara K,et al. A novel selective peroxisome proliferator-activated receptor alpha agonist,2-methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220),potently decreases plasma triglyceride and glucose leve [2]. Puddu A,et al. Pioglitazone attenuates the detrimental effects of advanced glycation end-products in the pancreatic beta cell line HIT-T15. Regul Pept. 2012 Aug 20;177(1-3):79-84. [3]. Kubota N,et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J Biol Chem. 2006 Mar 31;281(13):8748-55. [4]. Elrashidy RA,et al. Pioglitazone attenuates cardiac fibrosis and hypertrophy in a rat model of diabetic nephropathy. J Cardiovasc Pharmacol Ther. 2012 Sep;17(3):324-33 |
| Unit | Bottle |
| Specification | 10mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Differential expression profiles of long noncoding RNAs and mRNAs in human bone marrow mesenchymal stem cells after exposure to a high dosage of dexamethasone
Click to check >>Author:Li T. Xu Y. Wang Y. Jiang Y
IF:5.0810
Publish_to:Stem Cell Res Ther
PMID:33407832
Manual Download